Holen Sie sich die Stockscreener-App
17.45
0.40%
-0.07
Schlusskurs vom Vortag:
$17.52
Offen:
$17.45
24-Stunden-Volumen:
756.90K
Relative Volume:
1.02
Marktkapitalisierung:
$587.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+15.64%
1M Leistung:
+34.23%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$17.28
$18.37
1-Wochen-Bereich:
$15.10
$18.37
52-Wochen-Spanne:
$12.33
$21.47
Grail Inc Stock (GRAL) Company Profile
Firmenname
Grail Inc
Sektor
Branche
Telefon
650-771-9796
Adresse
1525 O'BRIEN DRIVE, MENLO PARK
Vergleichen Sie GRAL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
17.45 | 587.34M | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-10-17 | Eingeleitet | Guggenheim | Neutral |
Grail Inc Aktie (GRAL) Neueste Nachrichten
Grail initiated at equal weight by Morgan Stanley (NASDAQ:GRAL) - Seeking Alpha
Grail (NASDAQ:GRAL) Coverage Initiated by Analysts at Morgan Stanley - MarketBeat
Golden Grail Beverages Cancels Convertible Debt to Reduce Dilution - Yahoo Finance
Grail's CFO Aaron Freidin sells $426,937 in common stock By Investing.com - Investing.com South Africa
Grail's CFO Aaron Freidin sells $426,937 in common stock - Investing.com
GRAIL to Participate in Upcoming Investor Conferences - WV News
Golden Grail Beverages CEO Shares Global Vision in New Interview with SmallCapVoice.com - Yahoo Finance
GRAIL to Present at Piper Sandler and Evercore ISI Healthcare Conferences in December | GRAL Stock News - StockTitan
GRAIL uses lung cancer blood test to determine who needs post-surgery therapy most - Mugglehead
Grail tests first patient for TROPION-Lung12 Phase 3 study - TipRanks
GRAIL Launches FDA-Approved Phase 3 Trial for Breakthrough Lung Cancer Blood Test | AZN Stock News - StockTitan
(GRAL) Trading Report - Stock Traders Daily
Wolfe Research Begins Coverage on Grail (NASDAQ:GRAL) - MarketBeat
Wolfe starts Grail at Peer Perform on time and money needs - TipRanks
Grail initiated with a Peer Perform at Wolfe Research - Nasdaq
Golden Grail Beverages Corp. (OTC: GOGY) Retains SmallCapVoice.com Inc. - The Manila Times
Golden Grail Beverages Slashes Share Count 90%, Plans Strategic Acquisitions for 2025 | GOGY Stock News - StockTitan
GRAIL Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
PRIMECAP Management's Strategic Acquisition of GRAIL Inc Shares - GuruFocus.com
Grail Inc. Reports Strong Galleri Test Growth in Q3 2024 - Nasdaq
GRAIL, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
GRAIL Inc Reports Q3 2024 Revenue of $28.7 Million with Signific - GuruFocus.com
GRAIL Reports Third Quarter 2024 Financial Results - PR Newswire
Quantune joins quest for the holy grail of non-invasive glucose monitoring - TechCrunch
How to Take Advantage of moves in (GRAL) - Stock Traders Daily
Grail (GRAL) Scheduled to Post Earnings on Tuesday - MarketBeat
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - PR Newswire
Jim Cramer says Reddit’s surge is about ‘raw user power,’ calls it ‘holy grail’ for advertisers - CNBC
GRAIL to Announce Third Quarter 2024 Financial Results - StockTitan
(GRAL) Trading Advice - Stock Traders Daily
Google: The Bullish Pivot Before The Earnings Grail (NASDAQ:GOOG) - Seeking Alpha
GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation - The Cancer Letter
Nike x Wu-Tang Clan Reunite to Release Legendary Sneaker Grail — NIKE, Inc. - Nike
Illumina Wins Court Fight With EU Over $7 Billion Grail Deal - MSN
Real-world study of Grail’s Galleri consistent with trial data - BioWorld Online
The Jeff Bezos-backed cancer treatment company is being sold for eight billion dollars - Telegrafi
GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference - PR Newswire
Health Beat: The 'holy grail' of cancer screening - 69News WFMZ-TV
CEO & Director Of GRAIL Sold 51% Of Their Shares - Simply Wall St
Company commits not to try to crack ‘holy grail’ cement-free formula - Irish Independent
Grail appoints healthcare veteran Sarah Krevans to board By Investing.com - Investing.com Australia
Grail appoints healthcare veteran Sarah Krevans to board - Investing.com
GRAIL Appoints Sarah Krevans to Board of Directors - Quantisnow
Layoff Tracker: Takeda Cuts More Employees, Total Exceeds 1,300 in 2024 - BioSpace
Grail CEO Robert Ragusa sells $1.73 million in stock - Investing.com
How the (GRAL) price action is used to our Advantage - Stock Traders Daily
Health Headlines: Holy Grail of cancer screening - KPLC
GRAIL, Inc. (GRAL): Jeff Bezos Is Buying This Stock Now - Insider Monkey
Grail Inc. executive acquires over $1 million in company stock - Investing.com India
Grail Inc. executive acquires over $1 million in company stock By Investing.com - Investing.com South Africa
Finanzdaten der Grail Inc-Aktie (GRAL)
Es liegen keine Finanzdaten für Grail Inc (GRAL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.43%
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):